Three pharma projects worth SAR 926 mn announced at CPHI day two
The Kingdom’s pharma market is expected to grow at a 9.3% CAGR until 2027
Available in your choice of English or Arabic
The Kingdom’s pharma market is expected to grow at a 9.3% CAGR until 2027
Saudi holds more than 50% market share in MENA pharma market
The IPO is shaping up to be the year’s second largest offering
Tawuniya and Alfozan Holding are anchor investors in the offering
WHO-Saudi collaboration to expand Hajj Health Card to 3 mn pilgrims
Saudi-based health institutions are teaming up with partners from Europe and the US to boost the local pharma industry
Mohamed Alshamari is the new CEO of KSA Hospitals and Clinics
The loan carries a 13-year tenor
Something went wrong. Please refresh the page and/or try again.
Queue